亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Clinical outcomes of MED and iLESSYS® Delta for the treatment of lumbar central spinal stenosis and lateral recess stenosis: A comparison study

腰椎管狭窄症 椎管狭窄
作者
Boyu Wu,Chengjie Xiong,Lin-ying Tan,Dongdong Zhao,Feng Xu,Hui Kang
出处
期刊:Experimental and Therapeutic Medicine [Spandidos Publishing]
卷期号:20 (6): 1-1 被引量:6
标识
DOI:10.3892/etm.2020.9382
摘要

Microendoscopic discectomy (MED) is an established procedure used to treat lumbar central spinal stenosis (LCSS) and lateral recess stenosis (LRS). The Interlaminar Endoscopic Surgical System iLESSYS® Delta approach has been developed from the traditional interlaminar endoscopic technique for the treatment of LCSS and LRS. In the present study, MED was used as a reference to evaluate this newly developed approach. A total of 82 and 52 patients with radicular leg pain and/or neurogenic claudication symptoms were treated by spinal canal decompression using the MED or iLESSYS® Delta approach, respectively. The clinical outcomes of the patients were analyzed using the Modified MacNab's criteria, visual analogue scale (VAS) leg pain score, VAS back pain score and the Oswestry Disability Index (ODI) score. Finally, the effectiveness of the decompression was evaluated on a cross-sectional area of the dural sac (CSAD) at the disc level. The incision length in the iLESSYS® Delta group was significantly decreased compared with the MED group (P<0.05); however, the duration of the operation in the iLESSYS® Delta group was significantly longer compared with the MED group (P<0.05). The VAS score of the back and ODI score in the iLESSYS® Delta group were significantly decreased compared with the MED group at the 1-week follow-up (P<0.0125). The postoperative CSAD was also significantly increased in both groups compared with before the operation (P<0.05); however, there were no significant differences in the postoperative CSAD between the two groups. The good-to-excellent rates of the MED and iLESSYS® Delta approach were 89.0 and 90.4%, respectively, whereas the complication rates of the MED and iLESSYS® Delta system were 3.66 and 3.85% in the two groups, respectively. In conclusion, the iLESSYS® Delta approach was identified to be comparable with the MED approach for treating LCSS and LRS, demonstrating both precise and limited decompression. In addition, the iLESSYS® Delta approach may reduce the short-term back pain and promote faster recovery compared with the MED.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
16秒前
量子星尘发布了新的文献求助10
22秒前
朴素的山蝶完成签到 ,获得积分10
32秒前
34秒前
58秒前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
科研通AI5应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
黑大侠完成签到 ,获得积分10
1分钟前
1分钟前
思源应助sss采纳,获得10
2分钟前
量子星尘发布了新的文献求助10
2分钟前
梨子茶发布了新的文献求助10
2分钟前
2分钟前
sss发布了新的文献求助10
2分钟前
2分钟前
诚心的信封完成签到 ,获得积分10
2分钟前
科研通AI5应助科研通管家采纳,获得10
3分钟前
3分钟前
量子星尘发布了新的文献求助10
3分钟前
3分钟前
3分钟前
3分钟前
紫熊完成签到,获得积分10
3分钟前
3分钟前
雪流星完成签到 ,获得积分10
3分钟前
woxinyouyou完成签到,获得积分0
4分钟前
紫熊发布了新的文献求助30
4分钟前
4分钟前
4分钟前
5分钟前
量子星尘发布了新的文献求助10
5分钟前
5分钟前
5分钟前
沉沉完成签到 ,获得积分0
5分钟前
量子星尘发布了新的文献求助10
6分钟前
6分钟前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3960142
求助须知:如何正确求助?哪些是违规求助? 3506271
关于积分的说明 11128693
捐赠科研通 3238319
什么是DOI,文献DOI怎么找? 1789703
邀请新用户注册赠送积分活动 871870
科研通“疑难数据库(出版商)”最低求助积分说明 803069